Proprietary datasets that reveal mechanistic insights — not just patterns. Make high-confidence go/no-go decisions and reduce Phase 2/3 clinical trial failures by 60%+.
Over 60% of clinical trials fail in Phase 2/3 because existing AI and pharma models rely on correlative data, not mechanistic understanding. Without knowing why a drug works, we can't predict when it will fail.
We generate multi-scale, high-fidelity biological and chemical datasets designed to reveal causal relationships and mechanistic pathways — not just patterns.
High-fidelity experiments, perturbation studies, and multi-omics integration
Causal inference, biological pathways, and temporal dynamics mapping
Validated molecules with mechanistic confidence for clinical success
Automated phenomics, imaging, and perturbation studies at scale — 1000s of experiments per week
Transcriptomics, proteomics, and metabolomics integrated for complete biological views
Cell signaling, pathway mapping, and causal inference models that reveal the "why"
Time-series data capturing disease progression and drug response mechanisms
From oncology to rare diseases, our mechanistic approach accelerates discovery and reduces risk across diverse indications.
Identify resistance mechanisms and precision combination therapies
Decode immune cell signaling and inflammatory pathways
Uncover neural circuit mechanisms and neurodegenerative pathways
Generate mechanistic insights where data is scarce
We provide more than data — we deliver mechanistic confidence that reduces risk, accelerates timelines, and increases your probability of clinical success.
Lower Phase 2/3 failure rates by targeting validated mechanisms, not just correlations
Speed up discovery with ready-to-analyze mechanistic datasets and models
Discover novel targets and mechanisms that competitors haven't explored
Access exclusive datasets not available in public repositories
Direct integration with your existing discovery and development workflows
Work with our team of biologists, data scientists, and AI experts
Join leading pharma and AI companies leveraging mechanistic insights to reduce risk and accelerate their path to the clinic.